Mode
Text Size
Log in / Sign up

Whole-genome sequencing for antimicrobial resistance detection faces limitations in predicting functional phenotypesGenetic testing alone may not predict if bacteria resist drugs

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that WGS detection of resistance determinants does not guarantee a functional antimicrobial phenotype.

This mini-review explores the capabilities and limitations of using whole-genome sequencing (WGS) to detect antimicrobial resistance (AMR). The authors synthesize evidence regarding the transition from genotype to phenotype, noting that the mere presence of a resistance determinant does not necessarily establish a functional contribution to the antimicrobial phenotype. This is due to the loss of critical biological information, including gene integrity, expression state, promoter architecture, copy number, and genomic localization.

Furthermore, the review highlights that metagenomic antimicrobial resistance gene (ARG) detection cannot be directly equated with phenotypic resistance. The authors also note that prediction models trained on restricted clinical populations may lack generalizability across different species, lineages, and One Health compartments. These findings suggest that current methods often reduce multidimensional resistance architectures to binary presence-absence profiles, potentially leading to false-resistant or false-susceptible predictions.

To improve clinical utility, the authors advocate for context-aware and quantitative phenotype prediction. This approach would integrate long-read sequencing, transcriptomics, copy-number analysis, and population-aware sequencing with standardized phenotypic metadata and externally validated computational models. These findings suggest that while WGS is a powerful tool, its interpretation requires integration with broader biological and genomic contexts to improve accuracy in clinical settings.

How this fits prior evidence

This review addresses a gap in the technical interpretation of genomic data for antimicrobial resistance. While previous coverage noted that targeting gene flow offers a complementary strategy for controlling antimicrobial resistance and that phage strategies are being explored for antimicrobial resistance, this review specifically addresses the limitations of using WGS to predict functional phenotypes. It highlights that the presence of a resistance determinant does not guarantee a functional phenotype, which is a critical distinction for clinical interpretation of genomic data.

When doctors try to figure out if a bacteria strain is resistant to antibiotics, they often look for specific genetic markers. However, just finding a resistance gene in a sample does not always mean the drug won't work. Many biological factors, like how much of a gene is produced or how many copies exist, can change the outcome.

Researchers found that current prediction models can be limited. Because these models often simplify complex biology into a simple yes or no, they can lead to incorrect predictions. This is especially true when models are trained on small groups of patients and then applied to different species or environments.

To improve accuracy, experts suggest moving toward more detailed testing. This includes looking at how genes are expressed and using more advanced sequencing methods. These tools help provide a clearer picture of whether a drug will actually be effective against a specific infection.

What this means for you:
Finding a resistance gene does not always mean a drug won't work because many biological factors influence the outcome.

Common questions

Does finding a resistance gene mean an antibiotic won't work?

Not necessarily. While finding a resistance gene is a key step, it does not always mean the drug will fail. Factors like gene integrity, how much the gene is expressed, and the number of copies of that gene all play a role in whether the bacteria actually becomes resistant to the medicine.

Why is it hard to predict antibiotic resistance from DNA?

It is difficult because many biological factors are often ignored in simple tests. These include things like the promoter architecture and the specific strain background. When these complex details are reduced to a simple yes or no, it can lead to incorrect predictions about whether a drug will work.

How can scientists make these predictions more accurate?

Scientists can improve accuracy by using more advanced methods like long-read sequencing and transcriptomics. These methods look at how genes are actually used by the cell. Moving toward these context-aware models helps provide a more complete picture of how a drug will perform against a specific infection.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedOct 2026
View Original Abstract ↓
Whole-genome sequencing (WGS) has substantially improved the detection and surveillance of antimicrobial resistance (AMR) by enabling the rapid identification of acquired resistance genes, resistance-associated point mutations, and mobile genetic elements. However, the presence of a resistance determinant does not necessarily establish its functional contribution to the antimicrobial phenotype. This mini-review argues that a central limitation of current genotype-to-phenotype prediction is representational: multidimensional resistance architectures are frequently reduced to binary presence–absence profiles. Such representations disregard gene integrity, expression state, promoter architecture, copy number, genomic localization, regulatory topology, strain background, and within-isolate population heterogeneity. Using functionally silent determinants, pseudogenized resistance genes, inducible and dosage-dependent resistance, altered permeability and efflux, heteroresistance, and genomic-context dependence as examples, we examine how this loss of biological information can generate both false-resistant and false-susceptible predictions. We further discuss why metagenomic ARG detection cannot be directly equated with phenotypic resistance and why prediction models trained on restricted clinical populations may not generalize across species, lineages, and One Health compartments. Moving from determinant detection toward context-aware and quantitative phenotype prediction will require the selective integration of long-read sequencing, transcriptomics, copy-number analysis, population-aware sequencing, standardized phenotypic metadata, and externally validated computational models. The relevant unit of AMR prediction is therefore not the resistance gene alone, but its functional state within a specific genomic, cellular, population, and environmental context.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.